Studies on the haemolytic activity of circulating C1q-C3/C4 complexes

Molecular Immunology

Volumn 45, Issue 7, 2008, Pages 1893-1899

  Wouters, Diana ^a   Brouwer, Mieke C ^a   Daha, Mohamed R ^b   Hack, C Erik ^a  

^a SANQUIN RESEARCH   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Complement; Human; Inflammation

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT FIXATION; COMPLEMENT HEMOLYSIS TEST; COVALENT BOND; HEMOLYSIS; HUMAN; PRIORITY JOURNAL;

ANIMALS; CHROMATOGRAPHY, AFFINITY; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT C3; COMPLEMENT C3D; COMPLEMENT C4; HEMOLYSIS; HUMANS; POLYETHYLENE GLYCOLS; SHEEP;

EID: 39049103909     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.10.040     Document Type: Article

References (24)

1. Arlaud G.J., Gaboriaud C., Thielens N.M., Budayova-Spano M., Rossi V., and Fontecilla-Camps J.C. Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity. Mol. Immunol. 39 (2002) 383-394
2. Budayova-Spano M., Lacroix M., Thielens N.M., Arlaud G.J., Fontecilla-Camps J.C., and Gaboriaud C. The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex. EMBO J. 21 (2002) 231-239
3. Cooper N.R. The classical complement pathway: activation and regulation of the first complement component. Adv. Immunol. 37 (1985) 151-216
4. Dodds A.W., Ren X.D., Willis A.C., and Law S.K. The reaction mechanism of the internal thioester in the human complement component C4. Nature 379 (1996) 177-179
5. Gadjeva M., Dodds A.W., Taniguchi-Sidle A., Willis A.C., Isenman D.E., and Law S.K. The covalent binding reaction of complement component C3. J. Immunol. 161 (1998) 985-990
6. Hack C.E., Eerenberg-Belmer A.J., Hannema A.J., Out T.A., and Aalberse R.C. Polyethylene glycol enhances the binding of C1q to circulating immune complexes. J. Immunol. Methods 44 (1981) 211-221
7. Hack C.E., Paardekooper J., Smeenk R.J., Abbink J., Eerenberg A.J., and Nuijens J.H. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies. J. Immunol. 141 (1988) 1602-1609
8. Hoekzema R., Hannema A.J., Swaak T.J., Paardekooper J., and Hack C.E. Low molecular weight C1q in systemic lupus erythematosus. J. Immunol. 135 (1985) 265-271
9. Hoekzema R., Martens M., Brouwer M.C., and Hack C.E. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q. Mol. Immunol. 25 (1988) 485-494
10. Hostetter M.K., Thomas M.L., Rosen F.S., and Tack B.F. Binding of C3b proceeds by a transesterification reaction at the thiolester site. Nature 298 (1982) 72-75
11. McGrath F.D., Brouwer M.C., Arlaud G.J., Daha M.R., Hack C.E., and Roos A. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J. Immunol. 176 (2006) 2950-2957
12. Schumaker V.N., Zavodszky P., and Poon P.H. Activation of the first component of complement. Annu. Rev. Immunol. 5 (1987) 21-42
13. Sim R.B., Twose T.M., Paterson D.S., and Sim E. The covalent-binding reaction of complement component C3. Biochem. J. 193 (1981) 115-127
14. Tack B.F., Harrison R.A., Janatova J., Thomas M.L., and Prahl J.W. Evidence for presence of an internal thiolester bond in third component of human complement. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 5764-5768
15. Tenner A.J., Lesavre P.H., and Cooper N.R. Purification and radiolabeling of human C1q. J. Immunol. 127 (1981) 648-653
16. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 344 (2001) 1058-1066
17. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 344 (2001) 1140-1144
18. Wolbink G.J., Bollen J., Baars J.W., ten Berge R.J., Swaak A.J., Paardekooper J., and Hack C.E. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway. J. Immunol. Methods 163 (1993) 67-76
19. Wolbink G.J., Brouwer M.C., Buysmann S., ten Berge I.J., and Hack C.E. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J. Immunol. 157 (1996) 473-479
20. Wouters D., Wiessenberg H.D., Hart M., Bruins P., Voskuyl A., Daha M.R., and Hack C.E. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation. J. Immunol. Methods 298 (2005) 35-45
21. Wouters D., Voskuyl A.E., Molenaar E.T., Dijkmans B.A., and Hack C.E. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products. Arthritis Rheum. 54 (2006) 1143-1150
22. Ziccardi R.J. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition. J. Immunol. 136 (1986) 3378-3383
23. Ziccardi R.J. Studies on the mechanism of C3b inhibition of immune complex induced C1 activation. Mol. Immunol. 25 (1988) 1339-1346
24. Ziccardi R.J., and Cooper N.R. Demonstration and quantitation of activation of the first component of complement in human serum. J. Exp. Med. 147 (1978) 385-395